Scarica l'app Stockscreener
4.5746
1.39%
0.0646
Personalis Inc Borsa (PSNL) Ultime notizie
Personalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call Transcript - MSN
These Analysts Think Personalis, Inc.'s (NASDAQ:PSNL) Sales Are Under Threat - simplywall.st
Personalis outlines $70M–$80M revenue target for 2025 amid 59% sequential clinical test growth and revised biopharma outlook - MSN
All You Need to Know About Personalis (PSNL) Rating Upgrade to Buy - Yahoo Finance
Personalis, Inc. (NASDAQ:PSNL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - uk.finance.yahoo.com
HC Wainwright & Co. Maintains Buy Rating on Personalis, Lowers Price Target to $8.50 - AInvest
Personalis, Inc. shares fall 1.03% after-hours following a securities lawsuit against Tempus AI, Inc. - AInvest
A Quick Look at Today's Ratings for Personalis(PSNL.US), With a Forecast Between $6 to $9 - 富途牛牛
Personalis Reports Q2 2025 Financial Results - The Globe and Mail
Personalis Earnings Call: Growth Amidst Financial Challenges - TipRanks
Personalis (PSNL) Q2 Revenue Falls 24% - AOL.com
PSNL: HC Wainwright & Co. Lowers Target Price, Maintains Buy Rat - GuruFocus
Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - 富途牛牛
Personalis 2025 Q2 Earnings Sustained Losses Despite Sequential Clinical Growth - AInvest
Personalis: Strong Molecular Testing Growth and Strategic MRD Focus Support Buy Rating - TipRanks
Personalis Plunges 26.06% on Revenue Targets - AInvest
Personalis: Q2 Earnings Snapshot - Huron Daily Tribune
Personalis (PSNL) Q2 Revenue Falls 24% - The Motley Fool
Personalis (PSNL): Navigating Near-Term Headwinds, Positioning for MRD Market Domination - AInvest
Personalis' Q2 2025 Earnings Call: Dissecting Contradictions in Revenue Projections and Reimbursement Strategies - AInvest
Personalis Sees 59% Sequential Clinical Test Growth, Targets $70M-$80M in Revenue for 2025 - AInvest
Earnings call transcript: Personalis Q2 2025 reveals revenue miss, stock steady - Investing.com Canada
Personalis Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Personalis Inc. Q2 Financial Performance ReportNews and Statistics - IndexBox
PSNL Predicts Modest Revenue Growth in Q3 - GuruFocus
PERSONALIS Earnings Results: $PSNL Reports Quarterly Earnings - Quiver Quantitative
Personalis earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Healthcare firm Personalis' Q2 revenue misses estimates - MarketScreener
Personalis reports Q2 EPS (23c), consensus (24c) - TipRanks
Personalis Reports Second Quarter 2025 Financial Results - Yahoo Finance
What are analysts’ price targets for Personalis Inc. in the next 12 monthsNavigate the market with precision tools - Jammu Links News
How does Personalis Inc. compare to its industry peersInvest confidently with real-time updates - Jammu Links News
What drives Personalis Inc. stock priceGet alerts on the hottest stocks daily - Jammu Links News
How strong is Personalis Inc. company’s balance sheetRobust financial gains - Jammu Links News
What are the technical indicators suggesting about Personalis Inc.Unmatched profit growth - Jammu Links News
Is Personalis (NASDAQ:PSNL) Using Too Much Debt? - 富途牛牛
Personalis, Inc. (NASDAQ:PSNL) Stocks Pounded By 28% But Not Lagging Industry On Growth Or Pricing - simplywall.st
What makes Personalis Inc. stock price move sharplyFree Alert Feed for Momentum Based Picks - Newser
Top Risks to Consider Before Buying Personalis Inc. StockTrading Watchlist with Real Time Filters - Newser
Assembly Biosciences (NASDAQ:ASMB) & Personalis (NASDAQ:PSNL) Head-To-Head Contrast - Defense World
Does Personalis Inc. show high probability of reboundFree Low Risk High Return Opportunities - Newser
Key metrics from Personalis Inc.’s quarterly dataWatchlist Summary for Active Day Traders - Newser
News impact scoring models applied to Personalis Inc.Free High Conviction Intraday Stock Signals - Newser
What catalysts could drive Personalis Inc. stock higher in 2025Pre Market Review For Consistent Profits - Jammu Links News
Applying big data sentiment scoring on Personalis Inc.Summary of Consistent Growth Stock Picks - Newser
Why Personalis Inc. is moving todayBuy and Exit Strategy Based on Momentum - Newser
Tempus AI, Inc. (TEM) and Personalis Join Forces to Take on Colorectal Cancer - MSN
Personalis Inc. stock momentum explainedAI Swing Strategy Signal Forecasting System - Newser
Can swing trading help recover from Personalis Inc. lossesIntraday Price Forecast Using Volume Models - Newser
Developing predictive dashboards with Personalis Inc. dataEquity Signal Recap With Long-Term Summary - Newser
0.17%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):